Medicines Co
MDCO
MDCO was delisted on the 3rd of January, 2020.
284 hedge funds and large institutions have $8.36B invested in Medicines Co in 2019 Q4 according to their latest regulatory filings, with 107 funds opening new positions, 71 increasing their positions, 88 reducing their positions, and 66 closing their positions.
171% more funds holding in top 10
Funds holding in top 10: 14 → 38 (+24)
64% more capital invested
Capital invested by funds: $5.11B → $8.36B (+$3.25B)
62% more first-time investments, than exits
New positions opened: 107 | Existing positions closed: 66
18% more call options, than puts
Call options by funds: $1.12B | Put options by funds: $951M
14% more funds holding
Funds holding: 250 → 284 (+34)
19% less repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 88
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HI
HBK Investments
Dallas,
Texas
|
+$259M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$221M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$188M |
| 4 |
OP
Omni Partners
London,
United Kingdom
|
+$154M |
| 5 |
Citigroup
New York
|
+$152M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$709M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$625M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
-$340M |
| 4 |
SPC
Slate Path Capital
New York
|
-$192M |
| 5 |
MC
Maverick Capital
Dallas,
Texas
|
-$114M |
MDCO Hedge Fund Activity: Q4 2019 in Review
284 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q4 2019, worth a combined $8.36B — up 64% from $5.11B a quarter earlier.
Buyers outnumbered sellers: 107 funds opened new MDCO positions and 66 closed out — a net gain of 41 holders — while 71 added to existing stakes and 88 trimmed.
The largest buyer was HBK Investments, opening a new position worth an estimated $259M. The largest seller was Wellington Management Group, cutting an estimated $709M.
- 284 institutional investors held Medicines Co (MDCO) as of Q4 2019, up from 250 in Q3 2019.
- Funds reported $8.36B of Medicines Co stock for Q4 2019, up 64% quarter-over-quarter.
- 107 funds opened new Medicines Co positions in Q4 2019 and 66 closed out, a net change of +41 holders.
- The largest Medicines Co buyer in Q4 2019 was HBK Investments, an estimated $259M added.
- The largest Medicines Co seller in Q4 2019 was Wellington Management Group, an estimated $709M sold.
Based on aggregated 13F filings for Q4 2019.